Thursday, July 16, 2009

Friday File


Book and Blog Recommendations


Books

Garrison Keillor, my state’s answer to Mark Twain, often used a signature phrase on his radio show: “Be well, do good work, and keep in touch.” Michael S. Gazzaniga, brain scientist extraordinaire, says that this simple statement explains the essential difference between the cognitive complexity of humans and that of other primates. Put simply, “Other apes don’t have that sentiment.”

A cognitive neuroscientist at the University of California–Santa Barbara, Gazzaniga’s recent book, Human: The Science Behind What Makes Us Unique, looks at how we diverged from our ancestors to become sentient human beings. Hint: It has less to do with tool use and opposable thumbs than you might expect.

Gazzaniga wears his learning lightly and puts forth his ideas in an easy-going style. Though he does not mention them by name, he could have been thinking about PETA when he poses the ultimate question: “Would a chimp make a good date?”

Blogs

Neuroanthropology, a site dedicated to the “greater understanding of the encultured brain and body,” is another interdisciplinary gem of a blog.

In their own words, Neuroanthropology is a “collaborative weblog created to encourage exchanges among anthropology, philosophy, social theory, and the brain sciences. We especially hope to explore the implications of new findings in the neurosciences for our understanding of culture, human development, and behaviour.”

As part of that eclectic mix, Daniel Lende keeps a keen eye on the biology of drugs and alcohol, with a particular emphasis on “biopsychosocial” approaches to addiction.

Some of Neuroanthropology’s more popular posts include “Cultural Aspects of Post-Traumatic Stress Disorder,” “Sarah Palin and Language,” “Studying Sin,” and “How Your Brain is Not Like a Computer.” The site also features a great page of Web Resources.

Wednesday, July 15, 2009

Addiction Science and the Problem of Perception


Why don’t mental health professionals get it?

Dr. Joanna Moncrieff, identified by the BBC News as a “mental health expert,” gave the world the benefit of her view on the use of drugs for mental disorders in a July 15 article titled “The Myth of the Chemical Cure.”

Joanna Moncreiff’s version goes like this:

“If you've seen a doctor about emotional problems some time over the past 20 years, you may have been told that you had a chemical imbalance, and that you needed tablets to correct it. “

True.

“Magazines, newspapers, patients' organisations and internet sites have all publicised the idea that conditions like depression, anxiety, schizophrenia and bipolar disorder can be treated by drugs that help to rectify an underlying brain problem.”

True.

“People with schizophrenia and other conditions are frequently told that they need to take psychiatric medication for the rest of their lives to stabilise their brain chemicals, just like a diabetic needs to take insulin. The trouble is there is little justification for this view of psychiatric drugs.”

Deeply, undeniably false.

“First, although ideas like the serotonin theory of depression have been widely publicised, scientific research has not detected any reliable abnormalities of the serotonin system in people who are depressed.”

False—but a new and increasingly popular line of attack. None of the major findings about the relationship between serotonin metabolism and clinical unipolar depression has been overturned. The Serotonin hypothesis of unipolar depression is still a fundamentally sound and useful model, as evidence by the stunning success of serotonin-boosting antidepressants.

But wait! The success of SSRIs is proof that serotonin has nothing to do with it! Moncrieff writes: “It is frequently overlooked that drugs used in psychiatry are psychoactive drugs, like alcohol and cannabis. Psychoactive drugs make people feel different; they put people into an altered mental and physical state. They affect everyone, regardless of whether they have a mental disorder or not.”

False—all three statements. A trifecta of untruths. Psychoactive drugs for mental illness are not necessarily chemically akin to alcohol and cannabis, many of the drugs do not “make people feel different” or vault them into an altered mental state, and the drugs do not effect most “normal” people who do not have one of the underlying mental disorders the drugs are designed to treat.

“In my view it remains more plausible that they ‘work’ by producing drug-induced states which suppress or mask emotional problems.’

False—and happily, her view on the matter is not shared by many reputable neurologists. The quotation marks around the word “work” would seem to tell us all we need to know about Ms. Moncrieff’s relationship to modern medicine.

“At the moment people are being encouraged to believe that taking a pill will make them feel better by reversing some defective brain process.”

True--and we should thank our lucky stars that we have progressed out of the dark ages when it comes to the treatment of mental illness.

“If, on the other hand, we gave people a clearer picture, drug treatment might not always be so appealing.”

True—but on another hand, uncounted numbers of addicted people might find the prospect very appealing, if only they could afford it, or were under the care of a health professional who understood what the medication could do for her patients.

Graphics Credit: 1800blogger


Sunday, July 12, 2009

Stimulating Facts About Caffeine


Coffee highs and lows.

[Excerpted from “Caffeine: Pharmacology and Effects of the World’s Most Popular Drug,” by Kyle M. Clayton and Paula Lundberg-Love, in The Praeger International Collection on Addictions Volume 2]:

-- Caffeine dependence is not presently recognized as a clinical disorder in the American Psychological Association’s DSM-IV-TR. Caffeine intoxication, however, is listed as a distinct clinical syndrome. Most of the symptoms of caffeine intoxication resemble symptoms of cocaine or amphetamine overdose: anxiety, insomnia, restlessness, tremor, irritability, rambling speech patterns, and irregular heartbeat. “In adult cases of highly elevated doses,” the authors write, “symptoms such as fever, hallucinations, delusions and loss of consciousness have occurred.”

--In high enough doses, caffeine is extremely toxic and can lead to death. The good news: This almost never happens, since the potentially lethal dose is on the order of 50 to 100 cups of coffee, quickly consumed. There is, however, the theoretical risk that an overdose of caffeine tablets could be fatal.

--Caffeine tolerance develops in a hurry. Tolerance to the sleep-disrupting effects of coffee in high doses can occur after only seven days of consuming 400 mg of caffeine three times a day—using 120 mg per cup as a rough average, that amounts to about ten cups of strong coffee per day. The researchers report that “complete tolerance to subjective effects such as nervousness, tension, jitters and elevated energy were observed to develop after consuming 300 mg three times per day for 18 days, and it is possible that such tolerance can occur within a shorter period of time.”

--Caffeine can interfere with the effectiveness of benzodiazepines and other medications that act on the neurotransmitter GABA. “Caffeine can inhibit the binding of benzodiazepines to their specific receptors on the GABA-A receptor sites, therefore neutralizing the effects of such medications and inhibiting their sedative hypnotic effects. Such interactions should be considered when evaluating the effectiveness of medications used to treat insomnia.”

--Conversely, caffeine can enhance the effectiveness of pain relievers. In particular, caffeine allows for faster absorption of headache medications, producing faster relieve at lower doses. Nicotine increases the rate at which the body metabolizes caffeine. Abstinent cigarette smokers often discover that their usual intake of coffee causes jitters and a bad stomach once they quit smoking. Some researchers have speculated that a high level of caffeine intake during smoking cessation might cause an increase in nicotine withdrawal symptoms.

Photo Credit: www.healingwithnutrion.com

Thursday, July 9, 2009

Harm Reduction Scorecard


A look at drug strategies worldwide.

A fascinating study released earlier this year by the International Harm Reduction Association (IHRA) provides a snapshot of the staggering country-by-country variations in drug law and policy across the globe.

While Western Europe and North America have in place a solid base of operational heroin substitution therapies, such as methadone, these same Western countries have fallen behind in prison addiction programs, including all-important needle exchanges.

Countries lacking widespread access to heroin substitution programs include Russia, Afghanistan, Pakistan, Cambodia, and most of Latin America with the exception of Mexico. These are also, coincidentally or not, all regions of substantial opium cultivation.

As it turns out, every major nation except South Africa—where the ravages of HIV are all too evident--has put in place needle and syringe exchange programs of one scope or another, in at least one location in the country.

Interestingly, the IHRA report, titled “Harm Reduction Policy and Practice Wordwide,” finds that some of the countries with the most active needle exchange programs in prisons include Armenia, Kyrgyzstan, Romania—and Iran, which also offers heroin substitution therapy in prisons. Notable countries lacking widespread needle exchange programs in prisons include the United States, Latin America, and portions of Western Europe.

Finally, regarding the most radical category in the harm reduction arsenal—drug consumption rooms, also known as safe injection facilities—the world has been significantly slower to adopt this approach to the public consumption of injectable drugs. The document lists the existence of drug consumption rooms in Canada, Australia, Germany, Norway, the Netherlands, Spain, and Switzerland.

The report, prepared by Catherine Cook, a Research Analyst with IHRA, notes that the listings do not indicated “the scope, quality or coverage of services.” And while almost all countries have national policy documents that make reference to harm reduction policies for health or drug-related policy, strategies vary widely.

“Of particular interest here is the US,” the report notes, “which includes harm reduction in its national HIV and hepatitis C strategy documents, but not in those relating to drug policy.”


Graphic Credit: Bristol Drugs Project


Tuesday, July 7, 2009

What’s a Neurotransmitter, Anyway?


A brief guide for the perplexed.

A neurotransmitter is a chemical substance that carries impulses from one nerve cell to another. Neurotransmitters are manufactured by the body and are released from storage sacs in the nerve cells. A tiny junction, called the synaptic gap, lies between brain cells. (Think of Michelangelo’s Sistine Chapel, with the finger of Adam and the finger of God not quite touching, yet conveying energy and information.)

Neurotransmitters squirt across the synaptic gap, and this shower of chemical messengers lands on a field of tiny bumps attached to the surface of the nerve cell on the other side of the synaptic gap. These bumps are receptors, and they have distinctive shapes. Picture these receptors, brain researcher Candace Pert has suggested, as a field of lily pads floating on the outer oily surface of the cell.

Neurotransmitter molecules bind themselves tightly to these receptors. The fact that certain drugs of abuse also lock tightly into existing receptors, and send messages to nerve cells in the brain, is the key to the mystery of addiction.

The fact that certain drugs essentially “fool” receptors into receiving them is one of the most important and far-reaching discoveries in the history of modern science. It is the reason why even minute amounts of certain drugs can have such powerful effects on the human nervous system. The lock-and-key arrangement of neurotransmitters and their receptors is the fundamental architecture of action in the brain. Glandular cells are studded with receptors, and many of the hormones have their own receptors as well. If the drug fits the receptor and elicits a response, it is called an agonist. If it simply blocks the receptor site without stimulating a response, it is an antagonist. Still other neurotransmitters have only a secondary effect, causing the target cell to release other kinds of neurotransmitters and hormones.

Two of the most important neurotransmitters are serotonin and dopamine. The unfolding story of addiction science, at bottom, is the story of what has been learned about the nature and function of such chemicals, and the many and varied ways they effect the pleasure and reward centers in our brains.

In 1948, three researchers—Maurice Rapport, Arda Green, and Irvine Page—were looking for a better blood pressure medication. Instead, they managed to isolate a naturally occurring compound in beef blood called serotonin (pronounced sarah-tóne-in), and known chemically as 5-hydroxytryptamine, or simply 5-HT. The researchers determined that serotonin was involved in vasoconstriction, or narrowing of the blood vessels, and in that respect resembled another important chemical messenger in the brain—epinephrine, better known as adrenaline.

Even though there is at most 10 milligrams of the substance in our bodies, serotonin turned out to be one of nature’s signature chemicals—a chemical of thought, movement and behavior, as well as digestion, ejaculation, and evacuation. The body’s all-purpose neurotransmitter, involved in sleep, mood, appetite, among dozens of other functions. The cortex, the limbic system, the brain stem, the gut, the genitals, the bowels: serotonin is a key chemical messenger in all of it.

Another key neurotransmitter—dopamine—is considered to be one of the brain’s primary “pleasure chemicals,” and is found in areas of the brain linked to experiences of joy and reward.

Dopamine pathways play a role in carrying signals related to attention, movement, problem solving, pleasure, and the anticipation of rewarding experiences. Dopamine is one of the reasons why, after you have a pleasurable experience with food, drink, sex, or certain drugs, you are likely to feel a desire to repeat the experience. Dopamine is implicated in not just the drug high, but in the craving that accompanies withdrawal as well.

Feelings of pleasure, or joy, are natural drug highs. The fact that they are produced by chemical alterations in brain state does not make the fear or the pleasure feel any less real.

Excerpted from The Chemical Carousel: What Science Tells Us About Beating Addiction by Dirk Hanson © 2008


Photo Credit: NIDA

Sunday, July 5, 2009

Common Medicines That Can Kill You [Guest Post]


Legal but lethal.

[Today’s post was written by Kat Sanders, who regularly blogs on the topic of pharmacy technician certification. She welcomes your comments and questions at her email address: katsanders25@gmail.com.]

Medicines are supposed to save lives, but as with all things that are not used responsibly, they end up killing people more often than not when they are abused. It’s not just illegal drugs that kill; even the ones that are prescribed have the potential to become dangerous when they are not used as they are supposed to be. While we know that heroin, crack and other illegal substances cause death in the event of an overdose, we are not aware of many others that are relatively unknown, but just as dangerous. The below list is not exhaustive but details just a few of the drugs that could lead to death if abused.

NPF: Non-Pharmaceutical Fentanyl has been responsible for more than 1000 deaths (those that have been reported--there are definitely going to be many more that went unnoticed or unreported) between 2005 and 2007, according to the US Center for Disease Control and Prevention (CDC). NPF is a painkiller, one that is also illegally produced and sold because of its narcotic effects. Since it is much cheaper than heroin, sales are high, as are the deaths that it is responsible for. What people do not realize is that when this drug is produced illegally, it is 30 to 50 times more potent and risky than heroin.

Codeine: We would hardly think that the cough syrups we obtain over the counter could end up killing us, but the codeine they contain is a narcotic that causes hallucinations if taken in large amounts. And when cough syrups are abused, they could end up being potentially dangerous, like the case of Chad Butler, the rapper more popularly known as Pimp C. The singer already suffered from sleep apnea, and large amounts of codeine combined with sleep apnea is apparently enough to cause respiratory problems and cause death.

Acetaminophen (Paracetamol): While paracetamol alone cannot cause death, if you are a habitual drinker, your liver is already weak and damaged. And when you take large doses of paracetamol under such conditions, you may start feeling the symptoms in a day or two; you may experience a stomach ache, vomit, and feel pretty ill. Death, if it occurs, happens after four or five days after the overdose, if you do not take any treatment at all in the interim.

Opioid painkillers and Anti-depressants: This combination was responsible for killing up and coming actor Heath Ledger. The star, who was said to be increasingly despondent and depressed, was on anti-anxiety drugs and painkillers as part of his prescription. An overdose (a combination of six different drugs that included sedatives and painkillers) found him dead, just before the release of the blockbuster movie The Dark Knight, the latest in the Batman series and the one that saw him winning a posthumous Oscar for his devilish portrayal of the Joker.
The CDC reports that accidental drug overdoses are responsible for the death of more than 22,000 Americans every year. In fact, it is the second leading cause of preventable deaths, next to automobile accidents. And this is why we need to be extra careful and exercise caution when handling drugs and medicines.

Photo Credit: Canwest News Service

Friday, July 3, 2009

Friday File


Book and Blog Recommendations

Books

A decade ago, Dr. Jill Bolte Taylor, a brain researcher at Harvard Medical School and a national spokesperson for the Harvard Brain Bank, suffered a massive stroke at the age of 37. Unable to walk, talk, read, or write, Dr. Taylor underwent an 8-year recovery and narrates the story of her recovery in her book , My Stroke of Insight.

The book’s jacket copy explains: “As the damaged left side of her brain—the rational, grounded, detail-and-time oriented side—swung in and out of function, Taylor alternated between two distinct and opposite realities: the euphoric nirvana of the intuitive and kinesthetic right brain, in which she felt a sense of complete well-being and peace, and the logical, sequential left brain, which recognized Jill was having a stroke and enabled her to seek help before she was lost completely. “

As reporter Robert Koehler writes: “This book is about the wonder of being human and as such is a plea and a prayer that we strive to be equal to how big we really are. What a piece of work is man — 50 trillion cells functioning in purposeful harmony.”

Stroke patients, victims of brain injuries, medical practitioners, and the general reading public will find invaluable insights and recommendations in this book.

Blogs

The mission of Corpus Callosum, a science blog maintained by an anonymous psychiatrist who works at a community hospital, is “to develop connections between hard science and social science, using linear thinking and intuition; and to explore the relative merits of spontaneity vs. strategy.” The blog intelligently covers a broad range of general-interest topics, including social commentary, neuroscience, politics, and science news.

Corpus Callosum also regularly features excellent graphics and photographs, and is written in a reasoned, straightforward and easy-to-digest style. As a bonus, the site features a deep and high-quality blogroll.
Related Posts Plugin for WordPress, Blogger...